E-LIB Suche - Ergebnisse für: Lennerz, Jochen

1

Dimensions of health data Integrity:

Lennerz, Jochen K. ; Schneider, Nick ; Lauterbach, Karl
European Journal of Epidemiology. 39 (2024) 2 - p. 179-181 , 2024

Link: https://doi.org/10.1007/..

2

Radical surgical resection with molecular margins is associ..:

Massaad, Elie ; Smith, William J ; Bradley, Joseph...
Neuro-Oncology. , 2024

Link: https://doi.org/10.1093/..

3

POLYMER-BASED INTERFACE TARGETING INFLAMMATION IN ULCERATIV..:

Zhang, Sufeng ; Jin, Amy ; Lennerz, Jochen..
Inflammatory Bowel Diseases. 30 (2024) Supplement_1 - p. S4-S4 , 2024

Link: https://doi.org/10.1093/..

4

Diagnostic Test Utilization Management Strategies as an Opp..:

Hou, Helen X ; Li, Annie ; Thierauf, Julia C.
The Journal of Applied Laboratory Medicine. 9 (2024) 1 - p. 41-49 , 2024

Link: https://doi.org/10.1093/..

5

Reproducible Reporting of the Collection and Evaluation of ..:

Elfer, Katherine ; Gardecki, Emma ; Garcia, Victor...
Modern Pathology. 37 (2024) 4 - p. 100439 , 2024

Link: https://doi.org/10.1016/..

6

Training pathologists to assess stromal tumour‐infiltrating..:

Ly, Amy ; Garcia, Victor ; Blenman, Kim R M...
Histopathology. 84 (2024) 6 - p. 915-923 , 2024

Link: https://doi.org/10.1111/..

7

Supplementary Tables S1 to S5 from Allosteric PI3Kα Inhibit..:

Andreas Varkaris ; Ferran Fece de la Cruz ; Elizabeth E. Martin...
doi:10.1158/2159-8290.25191548.v1. , 2024

Link: https://doi.org/10.1158/..

8

Supplementary Figures S1 to S11 from Allosteric PI3Kα Inhib..:

Andreas Varkaris ; Ferran Fece de la Cruz ; Elizabeth E. Martin...
doi:10.1158/2159-8290.25183861.v1. , 2024

Link: https://doi.org/10.1158/..

9

Supplementary Tables S1 to S5 from Allosteric PI3Kα Inhibit..:

Andreas Varkaris ; Ferran Fece de la Cruz ; Elizabeth E. Martin...
doi:10.1158/2159-8290.25183858.v1. , 2024

Link: https://doi.org/10.1158/..

10

Supplementary Tables S1 to S5 from Allosteric PI3Kα Inhibit..:

Andreas Varkaris ; Ferran Fece de la Cruz ; Elizabeth E. Martin...
doi:10.1158/2159-8290.25183858.v1. , 2024

Link: https://doi.org/10.1158/..

11

Supplementary Figures S1 to S11 from Allosteric PI3Kα Inhib..:

Andreas Varkaris ; Ferran Fece de la Cruz ; Elizabeth E. Martin...
doi:10.1158/2159-8290.25191551.v1. , 2024

Link: https://doi.org/10.1158/..

12

Supplementary Figures S1 to S11 from Allosteric PI3Kα Inhib..:

Andreas Varkaris ; Ferran Fece de la Cruz ; Elizabeth E. Martin...
doi:10.1158/2159-8290.25183861.v1. , 2024

Link: https://doi.org/10.1158/..

13

Supplementary Tables S1 to S5 from Allosteric PI3Kα Inhibit..:

Andreas Varkaris ; Ferran Fece de la Cruz ; Elizabeth E. Martin...
doi:10.1158/2159-8290.25191548.v1. , 2024

Link: https://doi.org/10.1158/..

14

Supplementary Figures S1 to S11 from Allosteric PI3Kα Inhib..:

Andreas Varkaris ; Ferran Fece de la Cruz ; Elizabeth E. Martin...
doi:10.1158/2159-8290.25191551.v1. , 2024

Link: https://doi.org/10.1158/..

15

Molecular profiling and treatment pattern differences betwe..:

Spencer, Kristen ; Pappas, Leontios ; Baiev, Islam...
JNCI: Journal of the National Cancer Institute. 115 (2023) 7 - p. 870-880 , 2023

Link: https://doi.org/10.1093/..